IL1B and plasma cell myeloma: A recent study by Lust et al (2009) showed that neutralization of IL-1β (an osteoclast activating factor that also stimulates IL-6 production) with an IL-1 receptor antagonist (IL-1Ra, known as anakinra), slows the progression of smouldering to active multiple myeloma.